Aerska raises €32.0M Series A round
9 February 2026· Dublin, Ireland· health, biotech, ai, b2b, deep_hardware
The funding will be used to advance Aerska's antibody-oligo conjugate (AOC) platform toward clinical development for the treatment of degenerative neurological diseases such as Alzheimer's and Parkinson's.
Investors
LeadEQT Dementia Fund
Also participating
age1Iaso Ventures
About Aerska
Stage
Series A
Headquarters
Dublin, Ireland
Founded
2025
Team Size
21–50
Sectors
healthbiotechaib2bdeep_hardware
Source: https://www.irishtimes.com/business/2026/02/09/irish-biotech-aerska-raises-39m-in-funding/